PT2822964T - Identificação de mutações de canalrodopsina (chop2) e métodos de utilização - Google Patents

Identificação de mutações de canalrodopsina (chop2) e métodos de utilização

Info

Publication number
PT2822964T
PT2822964T PT13710253T PT13710253T PT2822964T PT 2822964 T PT2822964 T PT 2822964T PT 13710253 T PT13710253 T PT 13710253T PT 13710253 T PT13710253 T PT 13710253T PT 2822964 T PT2822964 T PT 2822964T
Authority
PT
Portugal
Prior art keywords
chop2
channelrhodopsin
mutations
identification
methods
Prior art date
Application number
PT13710253T
Other languages
English (en)
Portuguese (pt)
Inventor
Pan Zhuo-Hua
Original Assignee
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wayne State filed Critical Univ Wayne State
Publication of PT2822964T publication Critical patent/PT2822964T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/405Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT13710253T 2012-03-05 2013-03-05 Identificação de mutações de canalrodopsina (chop2) e métodos de utilização PT2822964T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261606663P 2012-03-05 2012-03-05

Publications (1)

Publication Number Publication Date
PT2822964T true PT2822964T (pt) 2018-11-29

Family

ID=47892055

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13710253T PT2822964T (pt) 2012-03-05 2013-03-05 Identificação de mutações de canalrodopsina (chop2) e métodos de utilização

Country Status (16)

Country Link
US (3) US10947281B2 (https=)
EP (1) EP2822964B1 (https=)
JP (3) JP6395611B2 (https=)
KR (1) KR102137717B1 (https=)
CN (2) CN104334575A (https=)
AU (4) AU2013230112A1 (https=)
CA (1) CA2866405A1 (https=)
DK (1) DK2822964T3 (https=)
EA (1) EA201491643A1 (https=)
ES (1) ES2703324T3 (https=)
HU (1) HUE040487T2 (https=)
MX (1) MX360085B (https=)
NZ (1) NZ629843A (https=)
PL (1) PL2822964T3 (https=)
PT (1) PT2822964T (https=)
WO (1) WO2013134295A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019588A4 (en) 2006-05-04 2010-11-24 Univ Wayne State RESTORATION OF VISUAL RESPONSES BY IN VIVO ADMINISTRATION OF NUCLEIC ACIDS OF RHODOPSIN
WO2011140279A1 (en) 2010-05-04 2011-11-10 Wayne State University Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
AU2013230112A1 (en) 2012-03-05 2014-09-25 Wayne State University Identification of channelrhodopsin-2 (Chop2) mutations and methods of use
US9730888B2 (en) 2013-03-14 2017-08-15 Wayne State University Method of enhancing delivery of therapeutic compounds to the eye
JP6469669B2 (ja) 2013-07-08 2019-02-13 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se オキシムエステル光開始剤
AU2015229464B2 (en) 2014-03-11 2021-07-22 Wayne State University A modified mGluR6 promoter and methods of use
RU2018142273A (ru) 2016-05-03 2020-06-03 Чжо-хуа Пань Способ улучшения опосредованной вирусами доставки генов в глаз с использованием ингибиторов протеасом
WO2017207745A1 (en) * 2016-06-03 2017-12-07 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Mutant light-inducible ion channel of channelrhodopsin
CA3034887A1 (en) * 2016-08-29 2018-03-08 Wayne State University Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof
WO2018106369A2 (en) * 2016-11-06 2018-06-14 Nanoscope Technologies Llc Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof
EP3609518A1 (en) * 2017-04-12 2020-02-19 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. New optogenetic tool
SI3720428T1 (sl) * 2017-12-04 2023-05-31 Laboratorios Salvat, S. A. Oftalmični lokalni sestavek, ki vsebuje dobesilno kislino za zdravljenje bolezni posteriornega očesnega segmenta
JP6567153B1 (ja) * 2018-09-28 2019-08-28 学校法人東北工業大学 対象化合物の特性の予測を行うための方法、コンピュータシステム、プログラム
WO2024226667A2 (en) * 2023-04-24 2024-10-31 Nanoscope Therapeutics Inc. Optogenetic modulation by multi-characteristic opsins for vision restoration and other applications thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4498919A (en) 1983-10-31 1985-02-12 Corning Glass Works Method for making colored photochromic prescription ophthalmic lenses
US6610287B1 (en) 1990-04-16 2003-08-26 The General Hospital Corporation Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
US5827702A (en) 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
CA2287495A1 (en) 1997-04-21 1998-10-29 University Of Florida Materials and methods for treatment of retinal diseases
WO2000015822A1 (en) 1998-09-17 2000-03-23 University Of Florida Methods for treatment of degenerative retinal diseases
CA2406743A1 (en) 2000-04-28 2001-11-08 The Trustees Of The University Of Pennsylvania Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
CA2442670A1 (en) 2001-04-13 2002-10-24 The Trustees Of The University Of Pennsylvania Method of treating or retarding the development of blindness
WO2003016486A2 (en) 2001-08-16 2003-02-27 Sloan Kettering Institute For Cancer Research Bio-synthetic photostimulators and methods of use
DE10216005A1 (de) 2002-04-11 2003-10-30 Max Planck Gesellschaft Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle
AU2003249318A1 (en) 2002-07-18 2004-02-09 The General Hospital Corp. Method for augmenting vision in persons suffering from photoreceptor cell degeneration
US7186699B2 (en) 2003-06-03 2007-03-06 Cell Genesys, Inc. Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
JP2007527738A (ja) 2003-11-05 2007-10-04 ニューロヴィジョン, インコーポレイテッド 視覚を改善するための方法および装置
EP1919497B1 (en) 2005-07-22 2020-02-12 The Board of Trustees of the Leland Stanford Junior University Light-activated cation channel and uses thereof
EP2019588A4 (en) 2006-05-04 2010-11-24 Univ Wayne State RESTORATION OF VISUAL RESPONSES BY IN VIVO ADMINISTRATION OF NUCLEIC ACIDS OF RHODOPSIN
WO2011140279A1 (en) * 2010-05-04 2011-11-10 Wayne State University Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
PL2614079T3 (pl) * 2010-09-08 2016-01-29 Max Planck Gesellschaft Zmutowana kanałowa rodopsyna 2
AU2013230112A1 (en) * 2012-03-05 2014-09-25 Wayne State University Identification of channelrhodopsin-2 (Chop2) mutations and methods of use
KR101639859B1 (ko) * 2014-03-06 2016-07-14 포항공과대학교 산학협력단 광 자극에 의한 미토콘드리아 활성의 시공간적 가역 조절 방법

Also Published As

Publication number Publication date
AU2019216638B2 (en) 2021-07-08
PL2822964T3 (pl) 2019-05-31
AU2017239601A1 (en) 2017-10-26
AU2021245195B2 (en) 2023-09-28
US20250066431A1 (en) 2025-02-27
HUE040487T2 (hu) 2019-03-28
HK1205744A1 (en) 2015-12-24
CN111378020A (zh) 2020-07-07
US10947281B2 (en) 2021-03-16
AU2013230112A1 (en) 2014-09-25
WO2013134295A1 (en) 2013-09-12
CN104334575A (zh) 2015-02-04
AU2021245195A1 (en) 2021-11-04
MX2014010664A (es) 2015-03-06
MX360085B (es) 2018-10-10
NZ629843A (en) 2017-03-31
NZ727041A (en) 2022-01-28
JP6395611B2 (ja) 2018-09-26
AU2017239601B2 (en) 2019-05-16
CA2866405A1 (en) 2013-09-12
KR102137717B1 (ko) 2020-07-27
EP2822964B1 (en) 2018-08-22
KR20140132401A (ko) 2014-11-17
JP2018134098A (ja) 2018-08-30
JP2019193656A (ja) 2019-11-07
AU2019216638A1 (en) 2019-09-05
ES2703324T3 (es) 2019-03-08
JP2015510759A (ja) 2015-04-13
US20150044181A1 (en) 2015-02-12
EP2822964A1 (en) 2015-01-14
US20220033449A1 (en) 2022-02-03
EA201491643A1 (ru) 2015-02-27
DK2822964T3 (en) 2018-12-10

Similar Documents

Publication Publication Date Title
PT2822964T (pt) Identificação de mutações de canalrodopsina (chop2) e métodos de utilização
SG10201609940RA (en) Compounds and their methods of use
ES3063081T3 (en) Anti-cd47 antibodies and methods of use thereof
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
HUE046178T2 (hu) Biomátrix hidrogélek és alkalmazási eljárásaik
ZA201405248B (en) Anesthetic compounds and related methods of use
EP2791333A4 (en) OPSINE POLYPEPTIDES AND METHODS OF USE
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
SG10201708580RA (en) Wireless stethoscope and method of use thereof
SG11201406894VA (en) Oilfield apparatus and methods of use
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
SG11201502757QA (en) Anti-c16orf54 antibodies and methods of use thereof
EP2806811A4 (en) VERTEBRAL CONSTRUCTION
ZA201500295B (en) Devices and methods for enhanced detection and identification of diseases
IL234841A0 (en) Administration forms of halofuginone and methods of use
SG10201608970SA (en) Oilfield apparatus and methods of use
AP2015008460A0 (en) Apparatus and methods of enhanced mobility management
IL239043B (en) Thrombin solution and methods of using it
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
ZA201405644B (en) Weatherised minerals and methods of making and using same
GB201222855D0 (en) Lock Means and Method of Use Thereof
GB201210911D0 (en) Clamping means and method of use thereof
GB201203663D0 (en) Note pad and method of use thereof